e-BioMatrix PostMarket Surveillance Registry
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip Urban, MD
Hôpital de La Tour
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arrixaca University Hospital
Murcia, Spain
- Inselspital
Bern, Switzerland
- Hôpital Cantonal de Fribourg
Fribourg, Switzerland
- Hôpitaux Universitaires de Genève
Geneva, Switzerland
- Cardiocentro Ticino
Lugano, Switzerland
- Hôpital de la Tour
Meyrin, Switzerland
- Triemli Hospital
Zurich, Switzerland
- Brighton-Sussex University Hospitals
Brighton, United Kingdom
- Manchester Heart Center
Manchester, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2008
- Primary completion
- 30 Sept 2012
- Completion
- 30 Sept 2014
- Last update posted
- 6 May 2019
- Registered enrollment
- 1,121
- Registry id
- NCT01254487
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.